NDC Package 49702-240-15 Cabenuva

Cabotegravir And Rilpivirine Kit - View Billable Units, 11-Digit Format, RxNorm

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
Package Description:
1 KIT in 1 CARTON * 3 mL in 1 VIAL (49702-238-01) * 3 mL in 1 VIAL (49702-243-02)
Product Code:
Proprietary Name:
Non-Proprietary Name:
Cabotegravir And Rilpivirine
Usage Information:
CABENUVA is indicated as a complete regimen for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults to replace the current antiretroviral regimen in those who are virologically suppressed (HIV-1 RNA less than 50 copies per mL) on a stable antiretroviral regimen with no history of treatment failure and with no known or suspected resistance to either cabotegravir or rilpivirine [see Clinical Studies (14.1)].
11-Digit NDC Billing Format:
Billing Unit:
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.
NDC to RxNorm Crosswalk:
  • RxCUI: 2475415 - {1 (3 ML cabotegravir 200 MG/ML Injection) / 1 (3 ML rilpivirine 300 MG/ML Injection) } Pack
  • RxCUI: 2475415 - cabotegravir 600 MG / rilpivirine 900 MG Extended Release Kit
  • RxCUI: 2475416 - {1 (3 ML cabotegravir 200 MG/ML Injection) / 1 (3 ML rilpivirine 300 MG/ML Injection) } Pack [CABENUVA 600 MG / 900 MG]
  • RxCUI: 2475416 - CABENUVA 600 MG / 900 MG Extended Release Kit
  • RxCUI: 2475417 - {1 (2 ML cabotegravir 200 MG/ML Injection) / 1 (2 ML rilpivirine 300 MG/ML Injection) } Pack
  • Product Type:
    Human Prescription Drug
    Labeler Name:
    Viiv Healthcare Company
    Dosage Form:
    Kit - A packaged collection of related material.
    Sample Package:
    FDA Application Number:
    Marketing Category:
    NDA - A product marketed under an approved New Drug Application.
    Start Marketing Date:
    Listing Expiration Date:
    Exclude Flag:
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 49702-240-15?

    The NDC Packaged Code 49702-240-15 is assigned to a package of 1 kit in 1 carton * 3 ml in 1 vial (49702-238-01) * 3 ml in 1 vial (49702-243-02) of Cabenuva, a human prescription drug labeled by Viiv Healthcare Company. The product's dosage form is kit and is administered via form.

    Is NDC 49702-240 included in the NDC Directory?

    Yes, Cabenuva with product code 49702-240 is active and included in the NDC Directory. The product was first marketed by Viiv Healthcare Company on January 21, 2021 and its listing in the NDC Directory is set to expire on December 31, 2025 if the product is not updated or renewed by the manufacturer.

    What is the NDC billing unit for package 49702-240-15?

    The contents of this package are billed per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.

    What is the 11-digit format for NDC 49702-240-15?

    The 11-digit format is 49702024015. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code